首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷醫院 IT

市場調查報告書

商品編碼

1439892

特別 PACS - 全球市場考量、競爭格局、市場預測 (2030)

Specialty PACS - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

預計2023年全球特種PACS市場規模將達到28.1532億美元，到2030年將達到43.0392億美元，2024-2030年預測期內複合年增長率為7.45%。由於全球乳癌發病率上升、心血管疾病盛行率上升、老年人口盛行率上升以及市場上專用 PACS 產品的快速成長等多種因素，該市場正在呈現正成長。因此，預計該市場將在 2024 年至 2030 年的預測期內成長。

特種PACS市場動態

專業 PACS 市場的主要驅動因素之一是全球乳癌盛行率的不斷上升。例如，根據世界衛生組織（WHO）2023年發佈的數據，2020年全球約有230萬名女性被診斷出罹患乳癌。根據上述資訊和統計，過去五年全球有780萬名女性被診斷出罹患乳癌。透過這種方式，專門的 PACS 充當乳房影像解決方案，提供患者的完整圖片並允許解讀乳房 X 光檢查等放射影像。因此，乳癌發生率的增加將增加對專業 PACS 的需求，並在預測期內（2024-2030 年）推動整個專業 PACS 市場向前發展。

此外，推動專業 PACS 市場成長的另一個主要因素是心血管疾病盛行率的上升。例如，根據英國心臟基金會2023年公佈的最新數據，2019年亞洲有32,376,834人被診斷出患有心血管疾病，12,543,833人患有冠狀動脈疾病，8,111,044人患有中風。透過這種方式，心臟病學中的 PACS 可以提供心臟病專家和技術人員在治療住院患者時可以使用的影像資訊。因此，心血管疾病盛行率的增加可能會增加對專業 PACS 的需求，進而為整個專業 PACS 市場的成長提供有利的環境。

此外，上述因素可能會增加對 PACS 的需求，並在 2024-2030 年預測期內大幅加速整個專業 PACS 市場的成長。

然而，與外科手術相關的複雜問題，例如專業 PACS 系統的高成本以及資料安全和隱私問題，可能會阻礙全球專業 PACS 市場的成長。

此外，持續的 COVID-19 大流行對專業 PACS 市場產生了重大影響。幾乎所有國家都實施了全國封鎖，旅行限制減少了非 COVID-19 患者就診的次數，生產現場缺乏勞動力阻礙了專業 PACS 產品的生產速度。然而，在 COVID-19 時代，特殊的 PACS 可以用於儲存並輕鬆存取受病毒感染的患者的身體影像。此外，隨著更多人接種疫苗、患者住院和門診限制放鬆以及供應鏈、物流和製造設施重新開放，專業 PACS 預計將在預測期內進一步成長。

專業 PACS 區隔市場分析

在專業 PACS 市場類型領域，放射學 PACS 預計將在 2023 年佔重要的收入佔有率。推動市場成長的主要功能包括能夠以高度組織和快速的方式傳輸、儲存和顯示放射學數據，從而產生更準確的結果。它還提供高品質的圖像並允許對圖像進行數位處理。

此外，與放射 PACS 相關的關鍵優勢可能會增加對專業 PACS 的需求，並在預測期內推動全球專業 PACS 市場的整體成長。另一方面，與專業PACS相關的合作夥伴關係的增加也是市場成長的驅動因素。

本報告研究和分析了全球專業 PACS 市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

推動專業 PACS 市場的因素
- 心血管疾病盛行率不斷上升
- 乳癌發生率不斷上升
- 老年人口增加
- 專業 PACS 產品在市場上的推出激增
專業 PACS 市場的限制與挑戰
- 專業 PACS 系統成本高昂
- 與外科手術相關的複雜問題，包括資料安全和隱私問題
專業 PACS 市場機會
- 增加專業 PACS 領域的研發活動
- 基於雲端的 PACS 的出現

第5章波特對專業 PACS 市場的五力分析

第 6 章 COVID-19 對專業 PACS 市場的影響分析

第7章PACS特殊市場佈局

依類型
- 放射 PACS
- 心臟 PACS
- 其他
依用途
- 乳房影像
- 骨科成像
- 心臟影像
- 輻射成像
按開發
- 基於網路
- 基於雲端
按最終用戶
- 醫院
- 影像中心
- 遠距放射學組織
按地區
- 北美
- 歐洲
- 亞太地區
- 其他領域

第 8 章特殊 PACS 市場：全球公司佔有率分析 - 3 至 5 家主要公司

第 9 章專業 PACS 市場公司與產品簡介

Novarad
IBM
Koninklijke Philips N.V
INFINITT Healthcare Co Ltd
FUJIFILM Holdings America Corporation
General Electric Company
PaxeraHealth
Siemens Medical Solutions USA Inc
Sectra AB
Topcon Corporation
Carestream Health
Intelerad Medical Systems Incorporated
Agfa-Gevaert Group
Hyland Software Inc
Mach7 Technologies
Amrita Technologies
Medsynaptic Pvt. Ltd
iCRco Inc
Konica Minolta Inc
SinoVision
O3 Enterprise s.r.l

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0569

Specialty PACS Market By Type (Radiology PACS, Cardiology PACS, And Others), By Application (Breast Imaging, Orthopedic Imaging, Cardiac Imaging, Radiologic Imaging, And Others), By Development (Web-Based Pacs And Cloud-Based), By End-User (Hospitals, Imaging Centers, And Teleradiology Organizations), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising incidence of cardiovascular diseases and increasing prevalence of breast cancer

The global Specialty Picture Archiving and Communication System (PACS) market was valued at USD 2815.32 million in 2023, growing at a CAGR of 7.45% during the forecast period from 2024 to 2030 to reach USD 4303.92 million by 2030. The specialty PACS market is witnessing a positive growth owing to various factors such as the increasing prevalence of breast cancer globally, rising incidence of cardiovascular diseases, rising prevalence of geriatric population and surge in the specialty PACS products launch in the market. Therefore, the market for specialty PACS is estimated to grow during the forecast period from 2024 to 2030.

Specialty PACS Market Dynamics:

One of the main drivers of the specialty PACS market is the increasing prevalence of breast cancer globally. For instance, according to the World Health Organization (WHO) published data in the year 2023, in 2020, approximately 2.3 million women were diagnosed with breast cancer worldwide. As per the above referenced source and statistics, around the world, 7.8 million women would have been diagnosed with breast cancer in the previous five years. Thus, specialty PACS act as a breast imaging solution, it gives the full patient overview and allows to read radiology images such as mammograms. Therefore, increasing the prevalence of breast cancer, increases the specialty PACS demand, thereby propelling the specialty PACS overall market forward over the forecast period (2024-2030).

Moreover, another key factor which is responsible for the growth of specialty PACS market is the rising incidence of cardiovascular diseases. For instance, according to the latest data published by the British Heart Foundation in the year 2023, in 2019, in Asia, 32,376,834 people were diagnosed with cardiovascular diseases, 12,543,833 individuals were affected with coronary artery disease, and 8,111,044 population was identified with stroke. Thus, PACS in cardiology provides imaging information which can be used by cardiologists and technicians while dealing with the inpatient care. Therefore, rising incidence of cardiovascular diseases, would uplift the demand of specialty PACS which in turn can provide a conductive growth environment for the specialty PACS overall market.

Furthermore, due to the factors mentioned above, the PACS demand will increase, which could surge the growth of the overall specialty PACS market during the forecast period from 2024 to 2030.

However, high cost of specialty PACS systems and complications related to surgical procedures such as data security & privacy issues, this can hamper the global specialty PACS market growth.

Additionally, the ongoing COVID-19 pandemic has significantly impacted the specialty PACS market. There was a nationwide lockdown in almost every country, movement restrictions declined the number of hospital visits other than COVID-19 patients and unavailability of the workforce at the production sites hampered the manufacturing rate of specialty PACS products. However, during the COVID-19 era specialty PACS could have been used to store and access images easily of patients body those who were suffering with the virus. Furthermore, with the masses being vaccinated, relaxation in the lockdown restrictions & the hospital visits of patients as well as resumption of supply chains, logistics, and manufacturing units, the specialty PACS can be expected to further grow during the forecast period.

Specialty PACS Market Segment Analysis:

Specialty PACS Market by Type (Radiology PACS, Cardiology PACS, and Others), Application (Breast Imaging, Orthopedic Imaging, Cardiac Imaging, Radiologic Imaging, and Others), Development (Web-Based and Cloud-Based), End-User (Hospitals, Imaging Centers, and Teleradiology Organizations), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the by-type segment of the specialty PACS market, radiology PACS is expected to hold a significant revenue share in the year 2023. The key attributes driving the growth of the specialty PACS market includes, that it allows radiology data to be transferred, stored, as well as viewed in a much organized and quick manner, resulting in more accurate outcomes. It also provides quality images and the ability to digitally manipulate the images.

Furthermore, the key benefits associated with radiology PACS would increase the demand for specialty PACS, which could drive the growth of the overall global specialty PACS market during the forecast period. However, an increasing number of partnerships associated with the specialty PACS also drives the market growth.

Also, in December 2022, Synapsica, an AI radiology reporting company announced the partnership with GenWorks Health, a healthcare solution provider backed by Wipro GE Healthcare, to bring its Picture Archiving and Communication System (PACS) to more cities across India. Its Radiolens radiology workflow solution automatically identifies poor quality scans and generates preliminary reports for most common modalities. Additionally, it offers both quantitative and qualitative actionable insights powered by Artificial Intelligence (AI). Through this partnership, the product will become accessible in over 300 tier 2 & 3 cities and towns, such as Maharashtra, Andhra Pradesh, West Bengal, and Chennai. The system has cleared both the United States and the European approval.

Furthermore, such type of activities and benefits associated with radiology PACS, in the type segment would result in the rising demand for specialty PACS which in turn would provide a conducive growth for the overall specialty PACS market during the forecast 2024-2030.

North America is expected to dominate the overall Specialty PACS Market:

Among all the regions, North America is expected to dominate the global specialty PACS market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. Factors such as the increasing prevalence of cardiovascular diseases and the surge in the specialty PACS products launch in the market are expected to increase the demand for specialty PACS in the North American market.

According to the latest data published by the British Heart Foundation in the year 2023, in 2019, in North America, the cardiovascular diseases affected 4,103,135 people, 1,089,947 people were diagnosed with coronary artery disease, and 498,551 had suffered from stroke. Thus, PACS in cardiology provides imaging information which can be used by cardiologists and technicians while dealing with the inpatient care. Therefore, rising incidence of cardiovascular diseases, can elevate the demand of specialty PACS, which would drive the overall specialty PACS market forward over the forecast period (2024-2030).

Furthermore, another factor that is responsible for the growth of specialty PACS market is the surge in the specialty PACS products launch in the market. For instance, in April 2020, Konica Minolta Healthcare Americas, a leader in medical diagnostics, released its Rede PACS, the company's most recent medical image management solution for specialized clinics, as well as Rede Mini PACS for managing ultrasound and X-ray images are now offered for sale in the US.

Therefore, due to interplay of the factors mentioned above, there will be high demand for specialty PACS, which would provide a conductive growth environment for the North American region in the specialty PACS market.

Specialty PACS Market Key Players:

Some of the key market players operating in the Specialty PACS market include Novarad, IBM, Koninklijke Philips N.V, INFINITT Healthcare Co Ltd, FUJIFILM Holdings America Corporation, General Electric Company, PaxeraHealth, Siemens Medical Solutions USA Inc, Sectra AB, Topcon Corporation, Carestream Health, Intelerad Medical Systems Incorporated, Agfa-Gevaert Group, Hyland Software Inc, Mach7 Technologies, Amrita Technologies, Medsynaptic Pvt. Ltd, iCRco Inc, Konica Minolta Inc, SinoVision, O3 Enterprise s.r.l, among others

Recent Developmental Activities in the Specialty PACS:

In October 2022, Ambra Health, a pioneer in cloud-based medical image management systems, has been acquired by Intelerad Medical Systems, a world leader in medical image management solutions. The unified platform will offer a superior cloud solution for reading, storing, and distributing diagnostic images to doctors, patients, and for researchers. Ambra adds a strong cloud VNA, image interchange functionality, research, and pathology capabilities to Intelerad's offering in addition to the company's award-winning PACS.

In August 2022, GE Healthcare, a manufacturer & distributor of diagnostic imaging agents as well as radiopharmaceuticals for imaging modalities used in medical imaging procedures, offers Edison True PACS, a diagnostic imaging and workflow solution created to assist radiologists. It is now accessible in the United States.

In November 2022, Change Healthcare, a leading healthcare technology company, announced that Stratus Imaging PACS, a cloud-native, zero-footprint Picture Archiving and Communication System, is live in clinical use. It offers radiology practitioners a seamless way to read pictures from many hospitals on a single platform, whenever they want, from anywhere, even at home and on mobile devices.

Key Takeaways from the Specialty PACS Market Report Study

Market size analysis for current specialty PACS market (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the specialty PACS market
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
Key companies dominating the global specialty PACS
Various opportunities are available for the other competitor in the specialty PACS market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current specialty PACS market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for specialty PACS market growth in the coming future?

Target Audience who can be benefited from this Specialty PACS Market Report Study

Specialty PACS providers
Research organizations and consulting companies
Specialty PACS -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in specialty PACS
Various end-users who want to know more about the specialty PACS market and latest technological developments in the specialty PACS

Frequently Asked Questions for Specialty PACS:

1. What is Specialty PACS?

Specialty PACS, a type of medical imaging technology widely utilized in healthcare organizations for the secure digital transmission of clinically important information and electronic pictures.

2. What is the market for Global Specialty PACS?

3. What are the drivers for the Global Specialty PACS market?

The specialty PACS market is witnessing a positive market growth owing to the factors such as the increasing prevalence of breast cancer globally, rising incidence of cardiovascular diseases, rising prevalence of geriatric population and surge in the specialty PACS products launch in the market.

4. Who are the key players operating in the Specialty PACS market?

Some of the key market players operating in the specialty PACS market include Novarad, IBM, Koninklijke Philips N.V, INFINITT Healthcare Co Ltd, FUJIFILM Holdings America Corporation, General Electric Company, PaxeraHealth, Siemens Medical Solutions USA Inc, Sectra AB, Topcon Corporation, Carestream Health, Intelerad Medical Systems Incorporated, Agfa-Gevaert Group, Hyland Software Inc, Mach7 Technologies, Amrita Technologies, Medsynaptic Pvt. Ltd, iCRco Inc, Konica Minolta Inc, SinoVision, O3 Enterprise s.r.l, and others

5. Which region has the highest share in Specialty PACS Market?

North America is expected to dominate the global specialty PACS market. Factors contributing to the growth of specialty PACS market in the North America region are the rising incidence of cardiovascular diseases and surge in the specialty PACS products launch in the market

1.Specialty PACS Market Report Introduction

2.Specialty PACS Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking

3. Regulatory Analysis

3.1. The US
3.2. Europe
3.3. Japan
3.4. China

4. Specialty PACS Market Key Factors Analysis

4.1. Specialty PACS Market Drivers
- 4.1.1. Rising Incidence of Cardiovascular Diseases
- 4.1.2. The Increasing Prevalence of Breast Cancer
- 4.1.3. Rising Prevalence of Geriatric Population
- 4.1.4. Surge in the Specialty PACS Products Launch in the Market
4.2. Specialty PACS Market Restraints And Challenges
- 4.2.1. High Cost of Specialty PACS Systems
- 4.2.2. Complications Related to Surgical Procedures such as Data Security & Privacy Issues
4.3. Specialty PACS Market Opportunities
- 4.3.1. Increasing Research and Development Activities in Specialty PACS
- 4.3.2. Emergence of cloud-based PACS

5. Specialty PACS Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Specialty PACS Market

7. Specialty PACS Market Layout

7.1. By Type
- 7.1.1. Radiology PACS
- 7.1.2. Cardiology PACS
- 7.1.3. Others
7.2. By Application
- 7.2.1. Breast Imaging
- 7.2.2. Orthopedic Imaging
- 7.2.4. Cardiac Imaging
- 7.2.4. Radiologic Imaging
- 7.2.5. Others
7.3. By Development
- 7.3.1. Web-Based
- 7.3.2. Cloud-Based
7.4. By End User
- 7.4.1. Hospitals
- 7.4.2. Imaging Centers
- 7.4.3. Teleradiology Organizations
7.5. By Geography
- 7.5.1. North America
  - 7.5.1.1. United States Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.1.2. Canada Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.1.3. Mexico Specialty PACS Market Size in USD million (2021-2030)
- 7.5.2. Europe
  - 7.5.2.1. France Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.2.2. Germany Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.2.3. United Kingdom Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.2.4. Italy Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.2.5. Spain Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.2.6. Russia Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.2.7. Rest of Europe Specialty PACS Market Size in USD million (2021-2030)
- 7.5.3. Asia-Pacific
  - 7.5.3.1. China Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.3.2. Japan Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.3.3. India Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.3.4. Australia Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.3.5. South Korea Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.3.6. Rest of Asia Pacific Specialty PACS Market Size in USD million (2021-2030)
- 7.5.4. Rest of the World (RoW)
  - 7.5.4.1. Middle East Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.4.2. Africa Specialty PACS Market Size in USD million (2021-2030)
  - 7.5.4.3. South America Specialty PACS Market Size in USD million (2021-2030)

8. Specialty PACS Market Global Company Share Analysis - Key 3-5 Companies

9. Specialty PACS Market Company and Product Profiles

9.1. Novarad
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. IBM
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. Koninklijke Philips N.V
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. INFINITT Healthcare Co Ltd
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4. Product Listing
- 9.4.5. Entropy
9.5. FUJIFILM Holdings America Corporation
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. General Electric Company
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. PaxeraHealth
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4. Product Listing
- 9.7.5. Entropy
9.8. Siemens Medical Solutions USA Inc
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. Sectra AB
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. Topcon Corporation
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. Carestream Health
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. Intelerad Medical Systems Incorporated
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. Agfa-Gevaert Group
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. Hyland Software Inc
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. Mach7 Technologies
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy
9.16. Amrita Technologies
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4. Product Listing
- 9.16.5. Entropy
9.17. Medsynaptic Pvt. Ltd
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4. Product Listing
- 9.17.5. Entropy
9.18. iCRco Inc
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4. Product Listing
- 9.18.5. Entropy
9.19. Konica Minolta Inc
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4. Product Listing
- 9.19.5. Entropy
9.20. SinoVision
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4. Product Listing
- 9.20.5. Entropy
9.21. O3 Enterprise s.r.l
- 9.21.1. Company Overview
- 9.21.2. Company Snapshot
- 9.21.3. Financial Overview
- 9.21.4. Product Listing
- 9.21.5. Entropy